Skip to content
10-Q

Quarterly Report

TENAX THERAPEUTICS, INC. TENX

0000950170-25-108063

← back to feed
Filed
Aug 13, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 11, 2025 4.56M sh
Shares Diluted Q2 2025 · Jun 30, 2025 39.57M sh
Shares Diluted Q2 2025 · Jun 30, 2025 38.09M sh
Shares Diluted Q2 2025 · Jun 30, 2024 1.96M sh
Shares Diluted Q2 2025 · Jun 30, 2024 1.59M sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$13.23M
Operating Cash Flow restated Q2 2025 · Jun 30, 2024 −$8.2M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $105.5M
Stockholders Equity Q2 2025 · Jun 30, 2025 $103.33M
Stockholders Equity Q2 2025 · Mar 31, 2025 $109.29M
Stockholders Equity Q2 2025 · Dec 31, 2024 $91.99M
Stockholders Equity restated Q2 2025 · Jun 30, 2024 $8.88M
Stockholders Equity restated Q2 2025 · Mar 31, 2024 $12.43M
Stockholders Equity restated Q2 2025 · Dec 31, 2023 $8.1M
Current Liabilities Q2 2025 · Jun 30, 2025 $2.53M
Current Liabilities Q2 2025 · Dec 31, 2024 $4.69M
Total Liabilities Q2 2025 · Jun 30, 2025 $2.53M
Total Liabilities Q2 2025 · Dec 31, 2024 $4.69M
Current Assets Q2 2025 · Jun 30, 2025 $105.86M
Current Assets Q2 2025 · Dec 31, 2024 $96.69M
Total Assets Q2 2025 · Jun 30, 2025 $105.86M
Total Assets Q2 2025 · Dec 31, 2024 $96.69M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.27
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.56
Eps Diluted Q2 2025 · Jun 30, 2024 −$1.83
Eps Diluted Q2 2025 · Jun 30, 2024 −$4.65
Eps Basic Q2 2025 · Jun 30, 2025 −$0.27
Eps Basic Q2 2025 · Jun 30, 2025 −$0.56
Eps Basic Q2 2025 · Jun 30, 2024 −$1.83
Eps Basic Q2 2025 · Jun 30, 2024 −$4.65
Rd Expense Q2 2025 · Jun 30, 2025 $6.12M
Rd Expense Q2 2025 · Jun 30, 2025 $11.8M
Rd Expense restated Q2 2025 · Jun 30, 2024 $2.33M
Rd Expense restated Q2 2025 · Jun 30, 2024 $5M
Net Income Q2 2025 · Jun 30, 2025 −$10.85M
Net Income Q2 2025 · Jun 30, 2025 −$21.26M
Net Income Q2 2025 · Mar 31, 2025 −$10.41M
Net Income restated Q2 2025 · Jun 30, 2024 −$3.58M
Net Income restated Q2 2025 · Jun 30, 2024 −$7.37M
Net Income Q2 2025 · Mar 31, 2024 −$3.8M
Operating Income Q2 2025 · Jun 30, 2025 −$11.79M
Operating Income Q2 2025 · Jun 30, 2025 −$23.13M
Operating Income restated Q2 2025 · Jun 30, 2024 −$3.67M
Operating Income restated Q2 2025 · Jun 30, 2024 −$7.58M
Revenue Q2 2025 · Jun 30, 2025 $0